Involvement of Adenosine A1 and A2A Receptors in the Motor Effects of Caffeine after its Acute and Chronic Administration
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
The involvement of adenosine A(1) and A(2A) receptors in the motor effects of caffeine is still a matter of debate. In the present study, counteraction of the motor-depressant effects of the selective A(1) receptor agonist CPA and the A(2A) receptor agonist CGS 21680 by caffeine, the selective A(1) receptor antagonist CPT, and the A(2A) receptor antagonist MSX-3 was compared. CPT and MSX-3 produced motor activation at the same doses that selectively counteracted motor depression induced by CPA and CGS 21680, respectively. Caffeine also counteracted motor depression induced by CPA and CGS 21680 at doses that produced motor activation. However, caffeine was less effective than CPT at counteracting CPA and even less effective than MSX-3 at counteracting CGS 21680. On the other hand, when administered alone in habituated animals, caffeine produced stronger motor activation than CPT or MSX-3. An additive effect on motor activation was obtained when CPT and MSX-3 were coadministered. Altogether, these results suggest that the motor-activating effects of acutely administered caffeine in rats involve the central blockade of both A(1) and A(2A) receptors. Chronic exposure to caffeine in the drinking water (1.0 mg/ml) resulted in tolerance to the motor effects of an acute administration of caffeine, lack of tolerance to amphetamine, apparent tolerance to MSX-3 (shift to the left of its 'bell-shaped' dose-response curve), and true cross-tolerance to CPT. The present results suggest that…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, functional interactions between A2A receptors and dopaminergic signaling pathways suggest that caffeine’s central stimulant effects likely arise from the broader disinhibition of a multi-neurotransmitter network, driven by concurrent antagonism of A1 and A2A receptors, rather than from blockade of a single receptor pathway alone [37,38].”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [38]
Citations
Cites
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
Ledent, C., Vaugeois, J.-M., Schiffmann, S. N., Pedrazzini, T., Yacoubi, M. E., Vanderhaeghen, J.-J., Costentin, J., Heath, J. K., Vassart, G., & Parmentier, M. (1997) · Nature · doi:10.1038/41771 · Cited by 918
Pontieri, F. E., Tanda, G., & Di Chiara, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12304 · Cited by 868
Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia
Ferré, S., Fuxe, K., B. Fredholm, B., Morelli, M., & Popoli, P. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01096-5 · Cited by 824
Self-citationAdenosine receptors and behavioral actions of methylxanthines.
Snyder, S. H., Katims, J. J., Annau, Z., Bruns, R. F., & Daly, J. W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.3260 · Cited by 694
(1962) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1962.tb27008.x · Cited by 586
Ferre, S., von Euler, G., Johansson, B., Fredholm, B. B., & Fuxe, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7238 · Cited by 552
Self-citationHillion, J., Canals, M., Torvinen, M., Casadó, V., Scott, R., Terasmaa, A., Hansson, A., Watson, S., Olah, M. E., Mallol, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107731200 · Cited by 500
Self-citation
Cited by
Ciruela, F., Casadó, V., Rodrigues, R. J., Luján, R., Burgueño, J., Canals, M., Borycz, J., Rebola, N., Goldberg, S. R., Mallol, J., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3574-05.2006 · Cited by 590
Self-citationAn Update on the Mechanisms of the Psychostimulant Effects of Caffeine
Ferré, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05196.x · Cited by 440
Self-citationDall'Igna, O. P., Fett, P., Gomes, M. W., Souza, D. O., Cunha, R. A., & Lara, D. R. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.008 · Cited by 372
Carriba, P., Ortiz, O., Patkar, K., Justinova, Z., Stroik, J., Themann, A., Müller, C., Woods, A. S., Hope, B. T., Ciruela, F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301375 · Cited by 260
Self-citationMechanisms of the psychostimulant effects of caffeine: implications for substance use disorders
Ferré, S. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4212-2 · Cited by 208
Self-citationAdenosine receptor targets for pain
Sawynok, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.031 · Cited by 199
Caffeine and the dopaminergic system
Cauli, O., & Morelli, M. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200503000-00001 · Cited by 195
Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease
Armentero, M. T., Pinna, A., Ferré, S., Lanciego, J. L., Müller, C. E., & Franco, R. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.07.004 · Cited by 192
Self-citationQuarta, D., Ferré, S., Solinas, M., You, Z., Hockemeyer, J., Popoli, P., & Goldberg, S. R. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02245.x · Cited by 163
Self-citationHattesohl, M., Feistel, B., Sievers, H., Lehnfeld, R., Hegger, M., & Winterhoff, H. (2007) · Phytomedicine · doi:10.1016/j.phymed.2007.11.027 · Cited by 186
Lovallo, W. R., Whitsett, T. L., al’Absi, M., Sung, B. H., Vincent, A. S., & Wilson, M. F. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000181270.20036.06 · Cited by 153
Adenosine A1-A2A receptor heteromers: New targets for caffeine in the brain
Ferre, S. (2008) · Frontiers in bioscience · doi:10.2741/2852 · Cited by 149
Bonaventura, J., Navarro, G., Casadó-Anguera, V., Azdad, K., Rea, W., Moreno, E., Brugarolas, M., Mallol, J., Canela, E. I., Lluís, C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507704112 · Cited by 148
Self-citationHodgson, R. A., Bertorelli, R., Varty, G. B., Lachowicz, J. E., Forlani, A., Fredduzzi, S., Cohen-Williams, M. E., Higgins, G. A., Impagnatiello, F., Nicolussi, E., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.149617 · Cited by 149
Role of the Central Ascending Neurotransmitter Systems in the Psychostimulant Effects of Caffeine
Ferré, S. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1400 · Cited by 132
Self-citationXanthines as Adenosine Receptor Antagonists
Müller, C. E., & Jacobson, K. A. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-13443-2_6 · Cited by 146
Self-citationAdenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry
Ferré, S., Diamond, I., Goldberg, S. R., Yao, L., Hourani, S. M. O., Huang, Z., Urade, Y., & Kitchen, I. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.04.002 · Cited by 150
Self-citationBeaumont, R., Cordery, P., Funnell, M., Mears, S., James, L., & Watson, P. (2017) · Journal of Sports Sciences · doi:10.1080/02640414.2016.1241421 · Cited by 130
“However, a cross-tolerance to the A1 receptor probably plays a more important role in mediating the development of tolerance (Karcz-Kubicha et al., 2003).”
BackgroundAdenosine–cannabinoid receptor interactions. Implications for striatal function
Ferré, S., Lluís, C., Justinova, Z., Quiroz, C., Orru, M., Navarro, G., Canela, E. I., Franco, R., & Goldberg, S. R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00723.x · Cited by 129
Self-citationQuarta, D., Borycz, J., Solinas, M., Patkar, K., Hockemeyer, J., Ciruela, F., Lluis, C., Franco, R., Woods, A. S., Goldberg, S. R., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02761.x · Cited by 120
Self-citationBlum, D., Galas, M.-C., Pintor, A., Brouillet, E., Ledent, C., Muller, C. E., Bantubungi, K., Galluzzo, M., Gall, D., Cuvelier, L., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05361.2003 · Cited by 116
Self-citationLopes, J. P., Pliássova, A., & Cunha, R. A. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.06.008 · Cited by 125
Schindler, C. W., Karcz‐Kubicha, M., Thorndike, E. B., Müller, C. E., Tella, S. R., Ferré, S., & Goldberg, S. R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706043 · Cited by 108
Self-citationOverexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety
Coelho, J. E., Alves, P., Canas, P. M., Valadas, J. S., Shmidt, T., Batalha, V. L., Ferreira, D. G., Ribeiro, J. A., Bader, M., Cunha, R. A., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00067 · Cited by 102
“However, this genetic manipulation does not reflect the effect of acutely administered A2AR agonists that reduce locomotor activity (48, 49).”
BackgroundFerré, S., Bonaventura, J., Zhu, W., Hatcher-Solis, C., Taura, J., Quiroz, C., Cai, N.-S., Moreno, E., Casadó-Anguera, V., Kravitz, A. V., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00243 · Cited by 100
“Since pharmacological blockade leads to significant locomotor activation (see below and Karcz-Kubicha et al., 2003; Orrú et al., 2011a), the reduced activity of A2AR−/− mice indicates the development of neuroadaptations that counteract the loss of an A2ARmediated tonic inhibitory effect of…”
BackgroundSelf-citationQuiroz, C., Luján, R., Uchigashima, M., Simoes, A. P., Lerner, T. N., Borycz, J., Kachroo, A., Canas, P. M., Orru, M., Schwarzschild, M. A., et al. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.143 · Cited by 97
Self-citationPreladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders
Hodgson, R. A., Bédard, P. J., Varty, G. B., Kazdoba, T. M., Paolo, T. D., Grzelak, M. E., Pond, A. J., Tahar, A. H., Bélanger, N., Grégoire, L., et al. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.07.011 · Cited by 95
Nunes, E. J., Randall, P. A., Santerre, J. L., Given, A. B., Sager, T. N., Correa, M., & Salamone, J. D. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.068 · Cited by 91
Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans
Orrù, M., Guitart, X., Karcz‐Kubicha, M., Solinas, M., Justinová, Z., Barodia, S. K., Zanoveli, J. M., Cortés, A., Lluís, C., Casadó, V., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.029 · Cited by 104
Self-citationPinna, A., Bonaventura, J., Farré, D., Sánchez‐Soto, M., Simola, N., Mallol, J., Lluı́s, C., Costa, G., Baqi, Y., Müller, C. E., et al. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2013.12.021 · Cited by 88
Self-citationFilip, M., Frankowska, M., Zaniewska, M., Przegaliński, E., Müller, C. E., Agnati, L. F., Franco, R., Roberts, D. C. S., & Fuxé, K. (2006) · Brain Research · doi:10.1016/j.brainres.2006.01.038 · Cited by 95
Self-citationPires, V. A., Pamplona, F. A., Pandolfo, P., Fernandes, D., Prediger, R. D. S., & Takahashi, R. N. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832a80bf · Cited by 84
Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies
Saraiva, S. M., Jacinto, T. A., Gonçalves, A. C., Gaspar, D., & Silva, L. R. (2023) · Pharmaceuticals · doi:10.3390/ph16081067 · Cited by 103
Nguyen, M. D., Lee, S. T., Ross, A. E., Ryals, M. M., Choudhry, V. I., & Venton, B. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087165 · Cited by 79
Purinergic contribution to amyotrophic lateral sclerosis
Volonté, C., Apolloni, S., Parisi, C., & Amadio, S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.026 · Cited by 80
Antoniou, K., Papadopoulou‐Daifoti, Z., Hyphantis, T. N., Papathanasiou, G., Bekris, E., Μαρσέλος, Μ., Panlilio, L. V., Müller, C. E., Goldberg, S. R., & Ferré, S. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0173-6 · Cited by 69
Self-citationDeurveilher, S., Lo, H., Murphy, J. A., Burns, J., & Semba, K. (2006) · Journal of Comparative Neurology · doi:10.1002/cne.21084 · Cited by 68
Wang, Z., Che, P.-L., Du, J., Ha, B., & Yarema, K. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013883 · Cited by 72
Rahimi, R. (2018) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-018-1780-7 · Cited by 70
Higgins, G. A., Grzelak, M. E., Pond, A. J., Cohen-Williams, M. E., Hodgson, R. A., & Varty, G. B. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.013 · Cited by 67
Sallaberry, C., Nunes, F., da Costa, M. S., Fioreze, G. T., Ardais, A. P., Botton, P. H. S., Klaudat, B., Forte, T., Souza, D. O., Elisabetsky, E., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.010 · Cited by 67
Justinová, Z., Ferré, S., Redhi, G. H., Mascia, P., Stroik, J., Quarta, D., Yaşar, S., Müller, C. E., Franco, R., & Goldberg, S. R. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00258.x · Cited by 58
Self-citationEffects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis
Potenza, R. L., Armida, M., Ferrante, A., Pèzzola, A., Matteucci, A., Puopolo, M., & Popoli, P. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23185 · Cited by 57
Self-citationRandall, P. A., Nunes, E. J., Janniere, S. L., Stopper, C. M., Farrar, A. M., Sager, T. N., Baqi, Y., Hockemeyer, J., Müller, C. E., & Salamone, J. D. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2198-3 · Cited by 57
Self-citationYu, L., Coelho, J. E., Zhang, X., Fu, Y., Tillman, A., Karaöz, U., Fredholm, B. B., Weng, Z., & Chen, J. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.90353.2008 · Cited by 61
Comparison of caffeine-induced locomotor activity between adolescent and adult rats
Marin, M. T., ZANCHETA, R. P., Paro, A. H., Possi, A. P. M., Cruz, F. C., & Planeta, C. S. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.052 · Cited by 65
Collins, L. E., Galtieri, D. J., Collins, P., Jones, S. K., Port, R. G., Paul, N. E., Hockemeyer, J., Müller, C. E., & Salamone, J. D. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.03.003 · Cited by 57
Self-citationPechlivanova, D., Tchekalarova, J. D., Nikolov, R. P., & YAKIMOVA, K. S. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.01.037 · Cited by 56
Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats
Solinas, M., Ferré, S., Antoniou, K. M., Quarta, D., Justinová, Z., Hockemeyer, J., Pappas, L. A., Segal, P. N., Wertheim, C. E., Müller, C. E., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2081-6 · Cited by 52
Self-citationJustinová, Z., Ferré, S., Segal, P. N., Antoniou, K. M., Solinas, M., Pappas, L. A., Highkin, J. L., Hockemeyer, J., Munzar, P., & Goldberg, S. R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056762 · Cited by 51
Self-citationPurinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy
Oliveira-Giacomelli, Á., Naaldijk, Y., Sardá-Arroyo, L., Gonçalves, M. C. B., Corrêa-Velloso, J., Pillat, M. M., de Souza, H. D. N., & Ulrich, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00325 · Cited by 50
“The A2A receptor has been reported as the main target for caffeine, a non-selective adenosine antagonist (Fredholm et al., 1999; Karcz-Kubicha et al., 2003).”
BackgroundIshiwari, K., MADSON, L., Farrar, A. M., Mingote, S., Valenta, J. P., DiGianvittorio, M., FRANK, L., Correa, M., Hockemeyer, J., & MULLER, C. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.12.020 · Cited by 49
Xiao, D., Cassin, J., Healy, B. C., Burdett, T. C., Chen, J., Fredholm, B. B., & Schwarzschild, M. A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.099 · Cited by 55
Effects of adenosine A2A receptor stimulation on cocaine-seeking behavior in rats
Bachtell, R. K., & Self, D. W. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1624-2 · Cited by 48
Differential effects of adenosine antagonists in two models of parkinsonian tremor
Trevitt, J. T., Kawa, K. H., Jalali, A., & Larsen, C. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.07.001 · Cited by 47
Orrù, M., Quiroz, C., Guitart, X., & Ferré, S. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.025 · Cited by 45
Self-citationTrevitt, J. T., Vallance, C., Harris, A., & Goode, T. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.02.001 · Cited by 47
The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease
Blum, D., Chern, Y., Domenici, M. R., Buée, L., Lin, C.-Y., Rea, W., Ferré, S., & Popoli, P. (2018) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2018.0006 · Cited by 45
Self-citationFeduccia, A. A., Wang, Y., Simms, J. A., Yi, H. Y., Li, R., Bjeldanes, L. F., Ye, C., & Bartlett, S. E. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.04.014 · Cited by 48
Porciúncula, L. O., Sallaberry, C., Mioranzza, S., Botton, P. H. S., & Rosemberg, D. B. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.09.009 · Cited by 50
Enabling role of adenosine A1receptors in adenosine A2Areceptor‐mediated striatal expression ofc‐fos
Karcz‐Kubicha, M., Quarta, D., Hope, B. T., Antoniou, K. M., Müller, C. E., Morales, M., Schindler, C. W., Goldberg, S. R., & Ferré, S. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02747.x · Cited by 43
Self-citationHsu, C. W., Chen, C. Y., Wang, C.-S., & Chiu, T. H. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1461-3 · Cited by 47
Acevedo, J. M., Almansa, A. S., Matos-Vergara, N., Marrero-Cordero, L. R., Cabezas-Bou, E., & Díaz‐Ríos, M. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.020 · Cited by 42
Kerkhofs, A., Xavier, A. C., da Silva, B. S., Canas, P. M., Idema, S., Baayen, J. C., Ferreira, S. G., Cunha, R. A., & Mansvelder, H. D. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00899 · Cited by 43
Noschang, C. G., Pettenuzzo, L. F., Toigo, E. V. P., Andreazza, A. C., Krolow, R., Fachin, A., Ávila, M. C., Arcego, D. M., Crema, L. M., Diehl, L. A., et al. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.07.007 · Cited by 48
ST 1535: a preferential A2A adenosine receptor antagonist
Stasi, M. A., Borsini, F., Varani, K., Vincenzi, F., Cesare, M. A. D., Minetti, P., Ghirardi, O., & Carminati, P. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006188 · Cited by 39
Cerri, S., Levandis, G., Ambrosi, G., Montepeloso, E., Antoninetti, G., Franco, R., Lanciego, J. L., Baqi, Y., Müller, C. E., Pinna, A., et al. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000064 · Cited by 40
Self-citationBjörklund, O., Kahlström, J., Salmi, P., & Fredholm, B. B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003977 · Cited by 37
“It is probably relevant that we have previously demonstrated that the ability of a low dose of caffeine to cause reinstatement of cocaineseeking behavior could be mimicked by A1-, but not by A2A receptor antagonists [38], even though A2A antagonists per se tend to produce at least as large increases in locomotion that…”
BackgroundCaffeine increases psychomotor performance on the effort expenditure for rewards task
Wardle, M. C., Treadway, M. T., & de Wit, H. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.06.016 · Cited by 39
Adenosine and dopamine receptor interactions in striatum and caffeine-induced behavioral activation.
Xie, X., Ramkumar, V., & Toth, L. A. (2007) · PubMed · Cited by 44
Amodeo, D. A., Cuevas, L., Dunn, J. T., Sweeney, J. A., & Ragozzino, M. E. (2017) · Autism Research · doi:10.1002/aur.1901 · Cited by 39
Lin, Y.-S., Weibel, J., Landolt, H., Santini, F., Meyer, M., Brunmair, J., Meier, S. M., Gerner, C., Borgwardt, S., Cajochen, C., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab005 · Cited by 38
de Oliveira, R. V., Dall'Igna, O. P. P., Tort, A. B. L., Schuh, J. F., Neto, P. F., Gomes, M. W. S., Souza, D. O., & Lara, D. R. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200503000-00002 · Cited by 36
Lorenzo, A., León, D., Castillo, C. A., Ruiz, M. A., Albasanz, J. L., & Martı́n, M. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22287 · Cited by 35
Agnati, L. F., Leo, G., Vergoni, A. V., Martı́nez, E., Hockemeyer, J., Lluı́s, C., Franco, R., Fuxé, K., & Ferré, S. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.06.003 · Cited by 34
Self-citationPardo, M., López‐Cruz, L., Valverde, O., Ledent, C. A., Baqi, Y., Müller, C. E., Salamone, J. D., & Correa, M. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.03.035 · Cited by 36
Self-citationMaternal caffeine intake affects acetylcholinesterase in hippocampus of neonate rats
da Silva, R. S., Richetti, S. K., da Silveira, V. G., Battastini, A. M. O., Bogo, M. R., Lara, D. R., & Bonan, C. D. (2008) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2007.12.006 · Cited by 32
Social environment modulates anxiogenic effects of caffeine in zebrafish
Neri, D., Ruberto, T., Mwaffo, V., Bartolini, T., & Porfiri, M. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000415 · Cited by 37
Zhang, R., Manza, P., & Volkow, N. D. (2021) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13495 · Cited by 38
Caffeine modulates P50 auditory sensory gating in healthy subjects
Ghisolfi, E. S., Schuch, A., Júnior, I. M. S., Luersen, G. F., Martins, F. F., Ramos, F. L. P., Becker, J., & Lara, D. R. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.09.001 · Cited by 33
Boeck, C. R., Marques, V. B., Valvassori, S. S., Constantino, L. C., Rosa, D. V., Lima, F. F., Romano‐Silva, M. A., & Quevedo, J. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.03.015 · Cited by 32
Effects of caffeine on reaction time are mediated by attentional rather than motor processes
Saville, C. W. N., de Morree, H. M., Dundon, N. M., Marcora, S., & Klein, C. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4790-7 · Cited by 39
Up-regulation of striatal adenosine A2A receptors with iron deficiency in rats
Quiroz, C., Pearson, V., Gulyani, S., Allen, R. P., Earley, C. J., & Ferré, S. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.04.004 · Cited by 40
Self-citationJustinová, Z., Ferré, S., Barnes, C., Wertheim, C. E., Pappas, L. A., Goldberg, S. R., & Foll, B. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1270-0 · Cited by 32
Self-citationWydra, K., Gołembiowska, K., Suder, A., Kamińska, K., Fuxé, K., & Filip, M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3675-2 · Cited by 36
Cechova, S., Elsobky, A. M., & Venton, B. J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.09.063 · Cited by 35
Adenosine A1 Receptor Blockade Mimics Caffeine's Attenuation of Ethanol‐Induced Motor Incoordination
Connole, L., Harkin, A., & Maginn, M. (2004) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2004.pto950509.x · Cited by 31
Caffeine in Food and Dietary Supplements: Examining Safety
Institute of Medicine (2014) · National Academies Press eBooks · doi:10.17226/18607 · Cited by 35
Adenosine receptor distribution in Rhesus monkey ocular tissue
Beach, K. M., Hung, L., Arumugam, B., Smith, E. L., & Ostrin, L. A. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.05.020 · Cited by 30
Combined effects of THC and caffeine on working memory in rats
Panlilio, L. V., Ferré, S., Yasar, S., Thorndike, E. B., Schindler, C. W., & Goldberg, S. R. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01554.x · Cited by 29
Self-citationPotential role of adenosine A2A receptors in the treatment of schizophrenia
Wardas, J. (2008) · Frontiers in bioscience · doi:10.2741/2995 · Cited by 35
The role of adenosine A2A receptors in Alzheimer's disease and tauopathies
Launay, A., Nebie, O., Shankara, J. V., Lebouvier, T., Buée, L., Faivre, É., & Blum, D. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109379 · Cited by 32
Chronic A2A antagonist treatment alleviates parkinsonian locomotor deficiency in MitoPark mice
Marcellino, D. J., Lindqvist, E., Schneider, M., Müller, C. E., Fuxé, K., Olson, L., & Galter, D. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.07.008 · Cited by 28
Self-citationEffects of 7-Methylxanthine on Deprivation Myopia and Retinal Dopamine Release in Chickens
Liu, H., Schaeffel, F., Trier, K., & Feldkaemper, M. P. (2019) · Ophthalmic Research · doi:10.1159/000502529 · Cited by 29
Sex Differences in Caffeine Neurotoxicity Following Chronic Ethanol Exposure and Withdrawal
Butler, T. R., Smith, K. J., Berry, J. N., Sharrett-Field, L. J., & Prendergast, M. (2009) · Alcohol and Alcoholism · doi:10.1093/alcalc/agp050 · Cited by 28
Gulyani, S., Earley, C. J., Camandola, S., Maudsley, S. R., Ferré, S., Mughal, M. R., Martin, B., Cheng, A., Gleichmann, M., Jones, B. C., et al. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.10.007 · Cited by 28
Self-citationQuiroz, C., Gomes, C. A., Pak, A. C., Ribeiro, J. A., Goldberg, S. R., Hope, B. T., & Ferré, S. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1661-06.2006 · Cited by 30
Self-citationAcute and adaptive motor responses to caffeine in adolescent and adult rats
Rhoads, D. E., Huggler, A. L., & Rhoads, L. J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.001 · Cited by 27
Lin, Y.-S., Weibel, J., Landolt, H., Santini, F., Slawik, H. C., Borgwardt, S., Cajochen, C., & Reichert, C. (2023) · Scientific Reports · doi:10.1038/s41598-022-26808-5 · Cited by 33
Montandon, G., Kinkead, R., & Bairam, A. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00514.2006 · Cited by 24
Metadata
- Authors
- Karcz-Kubicha, M., Antoniou, K., Terasmaa, A., Quarta, D., Solinas, M., Justinova, Z., Pezzola, A., Reggio, R., Müller, C. E., Fuxe, K., Goldberg, S. R., Popoli, P., & Ferré, S.
- Affiliations
- National Institutes of Health (US)
- Karolinska Institutet (SE)
- Istituto Superiore di Sanità (IT)
- University of Bonn (DE)
- Corresponding author
- Ferré, Sergi
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2003-01-20
- Volume
- 28
- Issue
- 7
- Pages
- 1281-1291
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2056124241
- Cited by
- 189
- References
- 60
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 8 · 2022: 3 · 2021: 5 · 2020: 1 · 2019: 8 · 2018: 14 · 2017: 7 · 2016: 6 · 2015: 10 · 2014: 12 · 2013: 7 · 2012: 8
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- caffeine, adenosine A1 receptor, adenosine A2A receptor, motor activation, caffeine tolerance, cross-tolerance, CPT, MSX-3, CPA, CGS 21680, receptor antagonists
- MeSH terms
- Adenosine, Amphetamine, Central Nervous System Stimulants, Animals, Behavior, Animal, Caffeine, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Interactions, Male, Motor Activity, Phenethylamines, Radioligand Assay, Theophylline, Time Factors, Triazines, Triazoles, Tritium, Xanthines, Rats, Sprague-Dawley, Receptors, Purinergic P1, Receptor, Adenosine A2A, Rats, Purinergic P1 Receptor Agonists, Purinergic P1 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.